Mark B. Pepys
Centre for Amyloidosis and Acute Phase Proteins
Department of Medicine
Royal Free and University College Medical School
Rowland Hill Street
UK
Name/email consistency: high
- MHC typing in variant Creutzfeldt-Jakob disease. Pepys, M.B., Bybee, A., Booth, D.R., Bishop, M.T., Will, R.G., Little, A.M., Prokupek, B., Madrigal, J.A. Lancet (2003)
- C-reactive protein: a critical update. Pepys, M.B., Hirschfield, G.M. J. Clin. Invest. (2003)
- Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Pepys, M.B., Herbert, J., Hutchinson, W.L., Tennent, G.A., Lachmann, H.J., Gallimore, J.R., Lovat, L.B., Bartfai, T., Alanine, A., Hertel, C., Hoffmann, T., Jakob-Roetne, R., Norcross, R.D., Kemp, J.A., Yamamura, K., Suzuki, M., Taylor, G.W., Murray, S., Thompson, D., Purvis, A., Kolstoe, S., Wood, S.P., Hawkins, P.N. Nature (2002)
- Pathogenesis, diagnosis and treatment of systemic amyloidosis. Pepys, M.B. Philos. Trans. R. Soc. Lond., B, Biol. Sci. (2001)
- C-reactive protein and atherothrombosis. Pepys, M.B., Hirschfield, G.M. Ital. Heart. J (2001)
- C-reactive protein and its role in the pathogenesis of myocardial infarction. Pepys, M.B., Hirschfield, G.M. Ital. Heart. J (2001)